29/04/2024
Medication Mondays ππ
Insulin is a high-risk medication (amongst others) - these are medications that have a high potential to cause harm should they be used incorrectly.
There are over 15 different types of insulin products available on the Australian market (various combinations, action profiles, devices - vial vs penfill vs disposable pen). You can see how quickly this can get so confusing.
Lets take insulin aspart as an example (refer to image attached)
All insulin aspart products in Australia are the same strength: 100units/ml, including Novorapid and the faster-acting Fiasp.
If the only information on a script is insulin aspart 100units/ml, it would be very hard to decipher which of the 6 insulin aspart products is the correct one.
To avoid errors and to prescribe insulin safely, along with the active ingredient/name of the insulin, your prescriber should always specify:
1. Brand name of the insulin E.g. Novorapid or Fiasp
2. Strength with "units" written in full rather than "u" E.g. 100 units per 1mL
3. Formulation E.g. Flexpen or Vial or Penfill or Cartridge
4. Route E.g. Subcutaneous injection or via insulin pump
5. Dose with units in full E.g. 5units (not applicable if being used in a pump)
6. Frequency and timing of the dose E.g. Inject 5 units with meals three times a day (not applicable if being used in a pump)
It is so important for anyone taking insulin to be aware of this, allowing you to confidently advocate for yourself.
More info available here:
https://www.safetyandquality.gov.au/sites/default/files/2022-11/safer_insulin_prescribing_-_guidance_for_australian_prescribers.pdf